2017-2022 Global and Japan Drugs for Sinusitis Market Analysis Report

August 2017 | 110 pages | ID: 2B31C2D5DDDEN
JP Research

Abstracts

The global Drugs for Sinusitis market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022.

Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2017, with a CAGR of xx%.

This report, with focus on top players in the global and Japan, studies the Drugs for Sinusitis market's development status and future trend in the global and Japan. It splits Drugs for Sinusitis market by type and by applications to fully and deeply research and reveal market profile and prospect.

The major players include

• Sanofi (FR)
• Bayer AG (DE)
• Pfizer (US)
• AstraZeneca Plc (UK)
• Novartis AG (CH)
• Johnson & Johnson (US)
• Merck (DE)
• Amgen (US)
• Bionorica SE （FR）
• Dr.Reddy's Laboratories （IN）
• Huasun （CN）

Geographically, this report splits the Global market into the following regions:

• Asia Pacific
• Japan
• Tokyo
• Yokohama
• Osaka
• Nagoya
• Others
• China
• Korea
• India
• Others
• Europe
• France
• Germany
• United Kingdom
• Italy
• Russia
• Others
• North America
• United States
• Canada
• Latin America
• Brazil
• Mexico
• Others
• Southeast Asia
• Singapore
• Malaysia
• Vietnam
• Myanmar
• Thailand
• Indonesia
• Philippines
• Others
• Middle East & Africa
• Saudi Arabia
• Iran
• UAE
• Turkey
• Israel
• Egypt
• South Africa
• Others

On the basis of product, the Drugs for Sinusitis market is primarily split into

By Product Type

• Antibiotics?
• Corticosteroids
• Decongestants
• Other

By Application

• Acute Sinusitis
• Chronic Sinusitis

Key Applications

• Hospital
• Medical Center
• Others

Contents

2017-2022 GLOBAL AND JAPAN DRUGS FOR SINUSITIS MARKET ANALYSIS REPORT

1 DRUGS FOR SINUSITIS OVERVIEW

1.1 Product Overview and Scope of Drugs for Sinusitis
1.2 Global and Japan Drugs for Sinusitis Market by Applications/End Users
  1.2.1 Japan Drugs for Sinusitis Sales (K Pcs) and Market Share Comparison by Applications (2012-2017)
    1.2.1.1 Japan Drugs for Sinusitis Sales (K Pcs) and Market Share by Applications (2012-2017)
    1.2.1.2 Japan Drugs for Sinusitis Sales Growth Rate (%) by Applications (2012-2017)
    1.2.1.3 Market Drivers and Opportunities
  1.2.2 Japan Drugs for Sinusitis Sales (K Pcs) and Market Share Comparison by Applications (2012-2017)
  1.2.3 Global Drugs for Sinusitis Sales by Application (2012-2017)
    1.2.3.1 Global Drugs for Sinusitis Sales (K Pcs) and Market Share by Applications (2012-2017)
    1.2.3.2 Global Drugs for Sinusitis Sales Growth Rate (%) by Applications (2012-2017)
    1.2.3.3 Market Drivers and Opportunities
  1.2.4 Global Drugs for Sinusitis Sales (K Pcs) and Market Share Comparison by Applications (2012-2017)
  1.2.5 Hospital
  1.2.6 Medical Center
  1.2.7 Others
1.3 Global and Japan Market Size (Sales and Revenue) of Drugs for Sinusitis (2012-2017)
  1.3.1 Japan Market Size (Sales and Revenue) of Drugs for Sinusitis (2012-2017)
    1.3.1.1 Japan Drugs for Sinusitis Sales (K Pcs) and Growth Rate (%) (2012-2017)
    1.3.1.2 Japan Drugs for Sinusitis Revenue (Million USD) and Growth Rate (2012-2017)
  1.3.2 Global Market Size (Sales and Revenue) of Drugs for Sinusitis (2012-2017)
    1.3.2.1 Global Drugs for Sinusitis Sales (K Pcs) and Growth Rate (%) (2012-2017)
    1.3.2.2 Global Drugs for Sinusitis Revenue (Million USD) and Growth Rate (2012-2017)
1.4 Global and Japan Classification of Drugs for Sinusitis by Product Type
  1.4.1 Japan Drugs for Sinusitis Sales (K Pcs) and Market Share by Product Type (2012-2017)
  1.4.2 Global Drugs for Sinusitis Sales (K Pcs) and Market Share by Product Type (2012-2017)
  1.4.3 Japan Drugs for Sinusitis Revenue (Million USD) and Market Share by Product Type (2012-2017)
  1.4.4 Global Drugs for Sinusitis Revenue (Million USD) and Market Share by Product Type (2012-2017)
  1.4.5 Japan Drugs for Sinusitis Price (USD/Pcs) by Product Type (2012-2017)
  1.4.6 Global Drugs for Sinusitis Price (USD/Pcs) by Product Type (2012-2017)
  1.4.7 Japan Drugs for Sinusitis Sales Growth Rate (%) by Product Type (2012-2017)
  1.4.8 Global Drugs for Sinusitis Sales Growth Rate (%) by Product Type (2012-2017)
  1.4.9 Antibiotics?
  1.4.10 Corticosteroids
  1.4.11 Decongestants
  1.4.12 Other
1.5 Global and Japan Classification of Drugs for Sinusitis by Application
  1.5.1 Japan Drugs for Sinusitis Sales (K Pcs) and Market Share by Application (2012-2017)
  1.5.2 Global Drugs for Sinusitis Sales (K Pcs) and Market Share by Application (2012-2017)
  1.5.3 Japan Drugs for Sinusitis Revenue (Million USD) and Market Share by Application (2012-2017)
  1.5.4 Global Drugs for Sinusitis Revenue (Million USD) and Market Share by Application (2012-2017)
  1.5.5 Japan Drugs for Sinusitis Price (USD/Pcs) by Application (2012-2017)
  1.5.6 Global Drugs for Sinusitis Price (USD/Pcs) by Application (2012-2017)
  1.5.7 Japan Drugs for Sinusitis Sales Growth Rate (%) by Application (2012-2017)
  1.5.8 Global Drugs for Sinusitis Sales Growth Rate (%) by Application (2012-2017)
  1.5.9 Acute Sinusitis
  1.5.10 Chronic Sinusitis

2 GLOBAL AND JAPAN DRUGS FOR SINUSITIS MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 Japan Drugs for Sinusitis Market Competition by Players/Manufacturers
  2.1.1 Japan Drugs for Sinusitis Sales and Market Share of Key Players/Manufacturers (2012-2017)
  2.1.2 Japan Drugs for Sinusitis Revenue and Share by Players/Manufacturers (2012-2017)
  2.1.3 Japan Drugs for Sinusitis Average Price (USD/Pcs) by Players/Manufacturers (2012-2017)
  2.1.4 Japan Drugs for Sinusitis Market Competitive Situation and Trends
    2.1.4.1 Japan Drugs for Sinusitis Market Concentration Rate
    2.1.4.2 Japan Drugs for Sinusitis Market Share of Top 3 and Top 5 Players/Manufacturers
    2.1.4.3 Mergers & Acquisitions, Expansion in Japan Market
  2.1.5 Japan Players/Manufacturers Drugs for Sinusitis Manufacturing Base Distribution, Sales Area, Product Types
2.2 Global Drugs for Sinusitis Market Competition by Players/Manufacturers
  2.2.1 Global Drugs for Sinusitis Sales and Market Share of Key Players/Manufacturers (2012-2017)
  2.2.2 Global Drugs for Sinusitis Revenue and Share by Players/Manufacturers (2012-2017)
  2.2.3 Global Drugs for Sinusitis Average Price (USD/Pcs) by Players/Manufacturers (2012-2017)
  2.2.4 Global Drugs for Sinusitis Market Competitive Situation and Trends
    2.2.4.1 Global Drugs for Sinusitis Market Concentration Rate
    2.2.4.2 Global Drugs for Sinusitis Market Share of Top 3 and Top 5 Players/Manufacturers
    2.2.4.3 Mergers & Acquisitions, Expansion in Global Market
  2.2.5 Global Players/Manufacturers Drugs for Sinusitis Manufacturing Base Distribution, Sales Area, Product Types

3 GLOBAL AND JAPAN DRUGS FOR SINUSITIS SALES AND REVENUE BY REGIONS (2012-2017)

3.1 Asia Pacific Drugs for Sinusitis Sales and Revenue by Regions (2012-2017)
  3.1.1 Japan Drugs for Sinusitis Sales and Revenue (2012-2017)
    3.1.1.1 Japan Drugs for Sinusitis Sales (K Pcs) and Market Share (2012-2017)
    3.1.1.2 Japan Drugs for Sinusitis Revenue (Million USD) and Market Share (2012-2017)
    3.1.1.3 Japan Drugs for Sinusitis Price (USD/Pcs)(2012-2017)
  3.1.2 China Drugs for Sinusitis Sales and Revenue (2012-2017)
    3.1.2.1 China Drugs for Sinusitis Sales (K Pcs) and Market Share (2012-2017)
    3.1.2.2 China Drugs for Sinusitis Revenue (Million USD) and Market Share (2012-2017)
    3.1.2.3 China Drugs for Sinusitis Price (USD/Pcs)(2012-2017)
  3.1.3 Korea Drugs for Sinusitis Sales and Revenue (2012-2017)
    3.1.3.1 Korea Drugs for Sinusitis Sales (K Pcs) and Market Share (2012-2017)
    3.1.3.2 Korea Drugs for Sinusitis Revenue (Million USD) and Market Share (2012-2017)
    3.1.3.3 Korea Drugs for Sinusitis Price (USD/Pcs)(2012-2017)
  3.1.4 India Drugs for Sinusitis Sales and Revenue (2012-2017)
    3.1.4.1 India Drugs for Sinusitis Sales (K Pcs) and Market Share (2012-2017)
    3.1.4.2 India Drugs for Sinusitis Revenue (Million USD) and Market Share (2012-2017)
    3.1.4.3 India Drugs for Sinusitis Price (USD/Pcs)(2012-2017)
  3.1.5 Others Drugs for Sinusitis Sales and Revenue (2012-2017)
    3.1.5.1 Others Drugs for Sinusitis Sales (K Pcs) and Market Share (2012-2017)
    3.1.5.2 Others Drugs for Sinusitis Revenue (Million USD) and Market Share (2012-2017)
    3.1.5.3 Others Drugs for Sinusitis Price (USD/Pcs)(2012-2017)
3.2 Europe Drugs for Sinusitis Sales and Revenue by Regions (2012-2017)
  3.2.1 France Drugs for Sinusitis Sales and Revenue (2012-2017)
    3.2.1.1 France Drugs for Sinusitis Sales (K Pcs) and Market Share (2012-2017)
    3.2.1.2 France Drugs for Sinusitis Revenue (Million USD) and Market Share (2012-2017)
    3.2.1.3 France Drugs for Sinusitis Price (USD/Pcs)(2012-2017)
  3.2.2 Germany Drugs for Sinusitis Sales and Revenue (2012-2017)
    3.2.2.1 Germany Drugs for Sinusitis Sales (K Pcs) and Market Share (2012-2017)
    3.2.2.2 Germany Drugs for Sinusitis Revenue (Million USD) and Market Share (2012-2017)
    3.2.2.3 Germany Drugs for Sinusitis Price (USD/Pcs)(2012-2017)
  3.2.3 United Kingdom Drugs for Sinusitis Sales and Revenue (2012-2017)
    3.2.3.1 United Kingdom Drugs for Sinusitis Sales (K Pcs) and Market Share (2012-2017)
    3.2.3.2 United Kingdom Drugs for Sinusitis Revenue (Million USD) and Market Share (2012-2017)
    3.2.3.3 United Kingdom Drugs for Sinusitis Price (USD/Pcs)(2012-2017)
  3.2.4 Italy Drugs for Sinusitis Sales and Revenue (2012-2017)
    3.2.4.1 Italy Drugs for Sinusitis Sales (K Pcs) and Market Share (2012-2017)
    3.2.4.2 Italy Drugs for Sinusitis Revenue (Million USD) and Market Share (2012-2017)
    3.2.4.3 Italy Drugs for Sinusitis Price (USD/Pcs)(2012-2017)
  3.2.5 Russia Drugs for Sinusitis Sales and Revenue (2012-2017)
    3.2.5.1 Russia Drugs for Sinusitis Sales (K Pcs) and Market Share (2012-2017)
    3.2.5.2 Russia Drugs for Sinusitis Revenue (Million USD) and Market Share (2012-2017)
    3.2.5.3 Russia Drugs for Sinusitis Price (USD/Pcs)(2012-2017)
  3.2.6 Others Drugs for Sinusitis Sales and Revenue (2012-2017)
    3.2.6.1 Others Drugs for Sinusitis Sales (K Pcs) and Market Share (2012-2017)
    3.2.6.2 Others Drugs for Sinusitis Revenue (Million USD) and Market Share (2012-2017)
    3.2.6.3 Others Drugs for Sinusitis Price (USD/Pcs)(2012-2017)
3.3 North America Drugs for Sinusitis Sales and Revenue by Regions (2012-2017)
  3.3.1 United States Drugs for Sinusitis Sales and Revenue (2012-2017)
    3.3.1.1 United States Drugs for Sinusitis Sales (K Pcs) and Market Share (2012-2017)
    3.3.1.2 United States Drugs for Sinusitis Revenue (Million USD) and Market Share (2012-2017)
    3.3.1.3 United States Drugs for Sinusitis Price (USD/Pcs)(2012-2017)
  3.3.2 Canada Drugs for Sinusitis Sales and Revenue (2012-2017)
    3.3.2.1 Canada Drugs for Sinusitis Sales (K Pcs) and Market Share (2012-2017)
    3.3.2.2 Canada Drugs for Sinusitis Revenue (Million USD) and Market Share (2012-2017)
    3.3.2.3 Canada Drugs for Sinusitis Price (USD/Pcs)(2012-2017)
3.4 Latin America Drugs for Sinusitis Sales and Revenue by Regions (2012-2017)
  3.4.1 Brazil Drugs for Sinusitis Sales and Revenue (2012-2017)
    3.4.1.1 Brazil Drugs for Sinusitis Sales (K Pcs) and Market Share (2012-2017)
    3.4.1.2 Brazil Drugs for Sinusitis Revenue (Million USD) and Market Share (2012-2017)
    3.4.1.3 Brazil Drugs for Sinusitis Price (USD/Pcs)(2012-2017)
  3.4.2 Mexico Drugs for Sinusitis Sales and Revenue (2012-2017)
    3.4.2.1 Mexico Drugs for Sinusitis Sales (K Pcs) and Market Share (2012-2017)
    3.4.2.2 Mexico Drugs for Sinusitis Revenue (Million USD) and Market Share (2012-2017)
    3.4.2.3 Mexico Drugs for Sinusitis Price (USD/Pcs)(2012-2017)
  3.4.3 Others Drugs for Sinusitis Sales and Revenue (2012-2017)
    3.4.3.1 Others Drugs for Sinusitis Sales (K Pcs) and Market Share (2012-2017)
    3.4.3.2 Others Drugs for Sinusitis Revenue (Million USD) and Market Share (2012-2017)
    3.4.3.3 Others Drugs for Sinusitis Price (USD/Pcs)(2012-2017)
3.5 Southeast Asia Drugs for Sinusitis Sales and Revenue by Regions (2012-2017)
  3.5.1 Singapore Drugs for Sinusitis Sales and Revenue (2012-2017)
    3.5.1.1 Singapore Drugs for Sinusitis Sales (K Pcs) and Market Share (2012-2017)
    3.5.1.2 Singapore Drugs for Sinusitis Revenue (Million USD) and Market Share (2012-2017)
    3.5.1.3 Singapore Drugs for Sinusitis Price (USD/Pcs)(2012-2017)
  3.5.2 Malaysia Drugs for Sinusitis Sales and Revenue (2012-2017)
    3.5.2.1 Malaysia Drugs for Sinusitis Sales (K Pcs) and Market Share (2012-2017)
    3.5.2.2 Malaysia Drugs for Sinusitis Revenue (Million USD) and Market Share (2012-2017)
    3.5.2.3 Malaysia Drugs for Sinusitis Price (USD/Pcs)(2012-2017)
  3.5.3 Vietnam Drugs for Sinusitis Sales and Revenue (2012-2017)
    3.5.3.1 Vietnam Drugs for Sinusitis Sales (K Pcs) and Market Share (2012-2017)
    3.5.3.2 Vietnam Drugs for Sinusitis Revenue (Million USD) and Market Share (2012-2017)
    3.5.3.3 Vietnam Drugs for Sinusitis Price (USD/Pcs)(2012-2017)
  3.5.4 Myanmar Drugs for Sinusitis Sales and Revenue (2012-2017)
    3.5.4.1 Myanmar Drugs for Sinusitis Sales (K Pcs) and Market Share (2012-2017)
    3.5.4.2 Myanmar Drugs for Sinusitis Revenue (Million USD) and Market Share (2012-2017)
    3.5.4.3 Myanmar Drugs for Sinusitis Price (USD/Pcs)(2012-2017)
  3.5.5 Thailand Drugs for Sinusitis Sales and Revenue (2012-2017)
    3.5.5.1 Thailand Drugs for Sinusitis Sales (K Pcs) and Market Share (2012-2017)
    3.5.5.2 Thailand Drugs for Sinusitis Revenue (Million USD) and Market Share (2012-2017)
    3.5.5.3 Thailand Drugs for Sinusitis Price (USD/Pcs)(2012-2017)
  3.5.6 Indonesia Drugs for Sinusitis Sales and Revenue (2012-2017)
    3.5.6.1 Indonesia Drugs for Sinusitis Sales (K Pcs) and Market Share (2012-2017)
    3.5.6.2 Indonesia Drugs for Sinusitis Revenue (Million USD) and Market Share (2012-2017)
    3.5.6.3 Indonesia Drugs for Sinusitis Price (USD/Pcs)(2012-2017)
  3.5.7 Philippines Drugs for Sinusitis Sales and Revenue (2012-2017)
    3.5.7.1 Philippines Drugs for Sinusitis Sales (K Pcs) and Market Share (2012-2017)
    3.5.7.2 Philippines Drugs for Sinusitis Revenue (Million USD) and Market Share (2012-2017)
    3.5.7.3 Philippines Drugs for Sinusitis Price (USD/Pcs)(2012-2017)
  3.5.8 Others Drugs for Sinusitis Sales and Revenue (2012-2017)
    3.5.8.1 Others Drugs for Sinusitis Sales (K Pcs) and Market Share (2012-2017)
    3.5.8.2 Others Drugs for Sinusitis Revenue (Million USD) and Market Share (2012-2017)
    3.5.8.3 Others Drugs for Sinusitis Price (USD/Pcs)(2012-2017)
3.6 Middle East & Africa Drugs for Sinusitis Sales and Revenue by Regions (2012-2017)
  3.6.1 Saudi Arabia Drugs for Sinusitis Sales and Revenue (2012-2017)
    3.6.1.1 Saudi Arabia Drugs for Sinusitis Sales (K Pcs) and Market Share (2012-2017)
    3.6.1.2 Saudi Arabia Drugs for Sinusitis Revenue (Million USD) and Market Share (2012-2017)
    3.6.1.3 Saudi Arabia Drugs for Sinusitis Price (USD/Pcs)(2012-2017)
  3.6.2 Iran Drugs for Sinusitis Sales and Revenue (2012-2017)
    3.6.2.1 Iran Drugs for Sinusitis Sales (K Pcs) and Market Share (2012-2017)
    3.6.2.2 Iran Drugs for Sinusitis Revenue (Million USD) and Market Share (2012-2017)
    3.6.2.3 Iran Drugs for Sinusitis Price (USD/Pcs)(2012-2017)
  3.6.3 UAE Drugs for Sinusitis Sales and Revenue (2012-2017)
    3.6.3.1 UAE Drugs for Sinusitis Sales (K Pcs) and Market Share (2012-2017)
    3.6.3.2 UAE Drugs for Sinusitis Revenue (Million USD) and Market Share (2012-2017)
    3.6.3.3 UAE Drugs for Sinusitis Price (USD/Pcs)(2012-2017)
  3.6.4 Turkey Drugs for Sinusitis Sales and Revenue (2012-2017)
    3.6.4.1 Turkey Drugs for Sinusitis Sales (K Pcs) and Market Share (2012-2017)
    3.6.4.2 Turkey Drugs for Sinusitis Revenue (Million USD) and Market Share (2012-2017)
    3.6.4.3 Turkey Drugs for Sinusitis Price (USD/Pcs)(2012-2017)
  3.6.5 Israel Drugs for Sinusitis Sales and Revenue (2012-2017)
    3.6.5.1 Israel Drugs for Sinusitis Sales (K Pcs) and Market Share (2012-2017)
    3.6.5.2 Israel Drugs for Sinusitis Revenue (Million USD) and Market Share (2012-2017)
    3.6.5.3 Israel Drugs for Sinusitis Price (USD/Pcs)(2012-2017)
  3.6.6 Egypt Drugs for Sinusitis Sales and Revenue (2012-2017)
    3.6.6.1 Egypt Drugs for Sinusitis Sales (K Pcs) and Market Share (2012-2017)
    3.6.6.2 Egypt Drugs for Sinusitis Revenue (Million USD) and Market Share (2012-2017)
    3.6.6.3 Egypt Drugs for Sinusitis Price (USD/Pcs)(2012-2017)
  3.6.7 South Africa Drugs for Sinusitis Sales and Revenue (2012-2017)
    3.6.7.1 South Africa Drugs for Sinusitis Sales (K Pcs) and Market Share (2012-2017)
    3.6.7.2 South Africa Drugs for Sinusitis Revenue (Million USD) and Market Share (2012-2017)
    3.6.7.3 South Africa Drugs for Sinusitis Price (USD/Pcs)(2012-2017)
  3.6.8 Others Drugs for Sinusitis Sales and Revenue (2012-2017)
    3.6.8.1 Others Drugs for Sinusitis Sales (K Pcs) and Market Share (2012-2017)
    3.6.8.2 Others Drugs for Sinusitis Revenue (Million USD) and Market Share (2012-2017)
    3.6.8.3 Others Drugs for Sinusitis Price (USD/Pcs)(2012-2017)

4 GLOBAL AND JAPAN DRUGS FOR SINUSITIS PLAYERS/MANUFACTURERS PROFILES AND SALES DATA

4.1 Sanofi (FR)
  4.1.1 Company Basic Information, Manufacturing Base and Competitors
  4.1.2 Drugs for Sinusitis Product Category, Application and Specification
    4.1.2.1 Product A
    4.1.2.2 Product B
  4.1.3 Sanofi (FR) Drugs for Sinusitis Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  4.1.4 Main Business/Business Overview
4.2 Bayer AG (DE)
  4.2.1 Company Basic Information, Manufacturing Base and Competitors
  4.2.2 Drugs for Sinusitis Product Category, Application and Specification
    4.2.2.1 Product A
    4.2.2.2 Product B
  4.2.3 Bayer AG (DE) Drugs for Sinusitis Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  4.2.4 Main Business/Business Overview
4.3 Pfizer (US)
  4.3.1 Company Basic Information, Manufacturing Base and Competitors
  4.3.2 Drugs for Sinusitis Product Category, Application and Specification
    4.3.2.1 Product A
    4.3.2.2 Product B
  4.3.3 Pfizer (US) Drugs for Sinusitis Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  4.3.4 Main Business/Business Overview
4.4 AstraZeneca Plc (UK)
  4.4.1 Company Basic Information, Manufacturing Base and Competitors
  4.4.2 Drugs for Sinusitis Product Category, Application and Specification
    4.4.2.1 Product A
    4.4.2.2 Product B
  4.4.3 AstraZeneca Plc (UK) Drugs for Sinusitis Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  4.4.4 Main Business/Business Overview
4.5 Novartis AG (CH)
  4.5.1 Company Basic Information, Manufacturing Base and Competitors
  4.5.2 Drugs for Sinusitis Product Category, Application and Specification
    4.5.2.1 Product A
    4.5.2.2 Product B
  4.5.3 Novartis AG (CH) Drugs for Sinusitis Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  4.5.4 Main Business/Business Overview
4.6 Johnson & Johnson (US)
  4.6.1 Company Basic Information, Manufacturing Base and Competitors
  4.6.2 Drugs for Sinusitis Product Category, Application and Specification
    4.6.2.1 Product A
    4.6.2.2 Product B
  4.6.3 Johnson & Johnson (US) Drugs for Sinusitis Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  4.6.4 Main Business/Business Overview
4.7 Merck (DE)
  4.7.1 Company Basic Information, Manufacturing Base and Competitors
  4.7.2 Drugs for Sinusitis Product Category, Application and Specification
    4.7.2.1 Product A
    4.7.2.2 Product B
  4.7.3 Merck (DE) Drugs for Sinusitis Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  4.7.4 Main Business/Business Overview
4.8 Amgen (US)
  4.8.1 Company Basic Information, Manufacturing Base and Competitors
  4.8.2 Drugs for Sinusitis Product Category, Application and Specification
    4.8.2.1 Product A
    4.8.2.2 Product B
  4.8.3 Amgen (US) Drugs for Sinusitis Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  4.8.4 Main Business/Business Overview
4.9 Bionorica SE （FR）
  4.9.1 Company Basic Information, Manufacturing Base and Competitors
  4.9.2 Drugs for Sinusitis Product Category, Application and Specification
    4.9.2.1 Product A
    4.9.2.2 Product B
  4.9.3 Bionorica SE （FR） Drugs for Sinusitis Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  4.9.4 Main Business/Business Overview
4.10 Dr.Reddy's Laboratories （IN）
  4.10.1 Company Basic Information, Manufacturing Base and Competitors
  4.10.2 Drugs for Sinusitis Product Category, Application and Specification
    4.10.2.1 Product A
    4.10.2.2 Product B
  4.10.3 Dr.Reddy's Laboratories （IN） Drugs for Sinusitis Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  4.10.4 Main Business/Business Overview
4.11 Huasun （CN）

5 DRUGS FOR SINUSITIS MANUFACTURING COST ANALYSIS

5.1 Drugs for Sinusitis Key Raw Materials Analysis
  5.1.1 Key Raw Materials
  5.1.2 Price Trend of Key Raw Materials
  5.1.3 Key Suppliers of Raw Materials
  5.1.4 Market Concentration Rate of Raw Materials
5.2 Proportion of Manufacturing Cost Structure
  5.2.1 Raw Materials
  5.2.2 Labor Cost
  5.2.3 Manufacturing Expenses
5.3 Manufacturing Process Analysis of Drugs for Sinusitis

6 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

6.1 Drugs for Sinusitis Industrial Chain Analysis
6.2 Upstream Raw Materials Sourcing
6.3 Raw Materials Sources of Drugs for Sinusitis Major Players/Manufacturers in 2016
6.4 Downstream Buyers

7 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

7.1 Marketing Channel
  7.1.1 Direct Marketing
  7.1.2 Indirect Marketing
  7.1.3 Marketing Channel Development Trend
7.2 Market Positioning
  7.2.1 Pricing Strategy
  7.2.2 Brand Strategy
  7.2.3 Target Client
7.3 Distributors/Traders List

8 MARKET EFFECT FACTORS ANALYSIS

8.1 Technology Progress/Risk
  8.1.1 Substitutes Threat
  8.1.2 Technology Progress in Related Industry
8.2 Consumer Needs/Customer Preference Change
8.3 Economic/Political Environmental Change

9 GLOBAL AND JAPAN DRUGS FOR SINUSITIS MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

9.1 Global and Japan Drugs for Sinusitis Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
9.2 Global and Japan Drugs for Sinusitis Sales (K Pcs) Forecast by Type (2017-2022)
  9.2.1 by Product Type
  9.2.2 by Application
9.3 Global and Japan Drugs for Sinusitis Sales (K Pcs) Forecast by Application (2017-2022)
9.4 Global and Japan Drugs for Sinusitis Sales (K Pcs) Forecast by Regions (2017-2022)

10 RESEARCH FINDINGS AND CONCLUSION

11 METHODOLOGY AND DATA SOURCE

11.1 Methodology/Research Approach
  11.1.1 Research Programs/Design
  11.1.2 Market Size Estimation
  11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
  11.2.1 Secondary Sources
  11.2.2 Primary Sources
11.3 Disclaimer
11.4 Author List

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Drugs for Sinusitis
Table Japan Drugs for Sinusitis Sales (Million Units) Comparison by Applications (2012-2017)
Figure Japan Sales Market Share (%) of Drugs for Sinusitis by Applications in 2016
Table Global Drugs for Sinusitis Sales (Million Units) Comparison by Applications (2012-2017)
Figure Global Sales Market Share (%) of Drugs for Sinusitis by Applications in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Medical Center Examples
Table Key Downstream Customer in Medical Center
Figure Others Examples
Table Key Downstream Customer in Others
Figure Antibiotics? Product Picture
Figure Corticosteroids Product Picture
Figure Decongestants Product Picture
Figure Other Product Picture
Figure Acute Sinusitis Product Picture
Figure Chronic Sinusitis Product Picture
Table Sanofi (FR) Basic Information List
Table Sanofi (FR) Drugs for Sinusitis Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Table Sanofi (FR) Drugs for Sinusitis Sales Growth Rate (%)(2012-2017)
Table Sanofi (FR) Drugs for Sinusitis Sales Market Share (%) in Japan (2012-2017)
Figure Sanofi (FR) Drugs for Sinusitis Revenue Market Share (%) in Japan (2012-2017)
Table Bayer AG (DE) Basic Information List
Table Bayer AG (DE) Drugs for Sinusitis Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Table Bayer AG (DE) Drugs for Sinusitis Sales Growth Rate (%)(2012-2017)
Table Bayer AG (DE) Drugs for Sinusitis Sales Market Share (%) in Japan (2012-2017)
Figure Bayer AG (DE) Drugs for Sinusitis Revenue Market Share (%) in Japan (2012-2017)
Table Pfizer (US) Basic Information List
Table Pfizer (US) Drugs for Sinusitis Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Table Pfizer (US) Drugs for Sinusitis Sales Growth Rate (%)(2012-2017)
Table Pfizer (US) Drugs for Sinusitis Sales Market Share (%) in Japan (2012-2017)
Figure Pfizer (US) Drugs for Sinusitis Revenue Market Share (%) in Japan (2012-2017)
Table AstraZeneca Plc (UK) Basic Information List
Table AstraZeneca Plc (UK) Drugs for Sinusitis Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Table AstraZeneca Plc (UK) Drugs for Sinusitis Sales Growth Rate (%)(2012-2017)
Table AstraZeneca Plc (UK) Drugs for Sinusitis Sales Market Share (%) in Japan (2012-2017)
Figure AstraZeneca Plc (UK) Drugs for Sinusitis Revenue Market Share (%) in Japan (2012-2017)
Table Novartis AG (CH) Basic Information List
Table Novartis AG (CH) Drugs for Sinusitis Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Table Novartis AG (CH) Drugs for Sinusitis Sales Growth Rate (%)(2012-2017)
Table Novartis AG (CH) Drugs for Sinusitis Sales Market Share (%) in Japan (2012-2017)
Figure Novartis AG (CH) Drugs for Sinusitis Revenue Market Share (%) in Japan (2012-2017)
Table Johnson & Johnson (US) Basic Information List
Table Johnson & Johnson (US) Drugs for Sinusitis Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Table Johnson & Johnson (US) Drugs for Sinusitis Sales Growth Rate (%)(2012-2017)
Table Johnson & Johnson (US) Drugs for Sinusitis Sales Market Share (%) in Japan (2012-2017)
Figure Johnson & Johnson (US) Drugs for Sinusitis Revenue Market Share (%) in Japan (2012-2017)
Table Merck (DE) Basic Information List
Table Merck (DE) Drugs for Sinusitis Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Table Merck (DE) Drugs for Sinusitis Sales Growth Rate (%)(2012-2017)
Table Merck (DE) Drugs for Sinusitis Sales Market Share (%) in Japan (2012-2017)
Figure Merck (DE) Drugs for Sinusitis Revenue Market Share (%) in Japan (2012-2017)
Table Amgen (US) Basic Information List
Table Amgen (US) Drugs for Sinusitis Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Table Amgen (US) Drugs for Sinusitis Sales Growth Rate (%)(2012-2017)
Table Amgen (US) Drugs for Sinusitis Sales Market Share (%) in Japan (2012-2017)
Figure Amgen (US) Drugs for Sinusitis Revenue Market Share (%) in Japan (2012-2017)
Table Bionorica SE （FR） Basic Information List
Table Bionorica SE （FR） Drugs for Sinusitis Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Table Bionorica SE （FR） Drugs for Sinusitis Sales Growth Rate (%)(2012-2017)
Table Bionorica SE （FR） Drugs for Sinusitis Sales Market Share (%) in Japan (2012-2017)
Figure Bionorica SE （FR） Drugs for Sinusitis Revenue Market Share (%) in Japan (2012-2017)
Table Dr.Reddy's Laboratories （IN） Basic Information List
Table Dr.Reddy's Laboratories （IN） Drugs for Sinusitis Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Table Dr.Reddy's Laboratories （IN） Drugs for Sinusitis Sales Growth Rate (%)(2012-2017)
Table Dr.Reddy's Laboratories （IN） Drugs for Sinusitis Sales Market Share (%) in Japan (2012-2017)
Figure Dr.Reddy's Laboratories （IN） Drugs for Sinusitis Revenue Market Share (%) in Japan (2012-2017)
Table Huasun （CN） Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Sinusitis
Figure Manufacturing Process Analysis of Drugs for Sinusitis
Figure Drugs for Sinusitis Industrial Chain Analysis
Table Raw Materials Sources of Drugs for Sinusitis Major Players/Manufacturers in 2016
Table Major Buyers of Drugs for Sinusitis
Table Distributors/Traders List
Figure Japan Drugs for Sinusitis Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
Figure Japan Drugs for Sinusitis Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Drugs for Sinusitis Price (USD/Pcs) Trend Forecast (2017-2022)
Figure Global Drugs for Sinusitis Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
Figure Global Drugs for Sinusitis Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Drugs for Sinusitis Price (USD/Pcs) Trend Forecast (2017-2022)
Table Japan Drugs for Sinusitis Sales (K Pcs) Forecast by Type (2017-2022)
Table Global Drugs for Sinusitis Sales (K Pcs) Forecast by Type (2017-2022)
Figure Japan Drugs for Sinusitis Sales (K Pcs) Forecast by Type (2017-2022)
Figure Global Drugs for Sinusitis Sales (K Pcs) Forecast by Type (2017-2022)
Figure Japan Drugs for Sinusitis Sales Volume Market Share Forecast by Type in 2017
Figure Global Drugs for Sinusitis Sales Volume Market Share Forecast by Type in 2017
Table Japan Drugs for Sinusitis Sales (K Pcs) Forecast by Application (2017-2022)
Figure Japan Drugs for Sinusitis Sales Volume Market Share Forecast by Application (2017-2022)
Figure Japan Drugs for Sinusitis Sales Volume Market Share Forecast by Application in 2017
Table Global Drugs for Sinusitis Sales (K Pcs) Forecast by Application (2017-2022)
Figure Global Drugs for Sinusitis Sales Volume Market Share Forecast by Application (2017-2022)
Figure Global Drugs for Sinusitis Sales Volume Market Share Forecast by Application in 2017
Table Japan Drugs for Sinusitis Sales (K Pcs) Forecast by Regions (2017-2022)
Table Japan Drugs for Sinusitis Sales Volume Share Forecast by Regions (2017-2022)
Figure Japan Drugs for Sinusitis Sales Volume Share Forecast by Regions (2017-2022)
Table Global Drugs for Sinusitis Sales (K Pcs) Forecast by Regions (2017-2022)
Table Global Drugs for Sinusitis Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Drugs for Sinusitis Sales Volume Share Forecast by Regions (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources